Novadaq Technologies

Novadaq Technologies — the American developer of technologies of medical visualization thanks to which surgeons gain an evident impression a bed in vessels and fabric perfusion within cardiovascular, gastrointestinal, plastic and microsurgeries.

2017: Stryker buys Novadaq for $700 million

On June 19, 2017 the producer of the medical equipment Stryker announced purchase of Novadaq Technologies for $701 million. The transaction was closed at the beginning of September.

Under the terms of the agreement, Stryker acquired all shares of Novadaq at the price of $11.75 apiece that 96% more than a quotation rate to the last before the declaration of the transaction to closing of the exchange.

Stryker headquarters

Stryker will pay all amount from own means, i.e. without attraction of the credits. In case of failure of the transaction the company would have to pay compensation in the amount of $21 million.

This acquisition corresponds to how we pay to clients attention that they could see and do more due to improvement of cross-disciplinary surgical visualization — the president of division of Stryker MedSurg and NeuroTechnology Timothy Scannell says. — The unique innovative technology of Novadaq supplements our product portfolio in the field of visualization and expands the range of solutions for open and plastic reconstructive surgery. Their advanced technology will be able to reduce the level of postoperative complications and cost of medical care after different surgical interventions.

Due to merger of Novadaq the Stryker company hopes to increase net profit by 3-5 cents counting on one action at the end of 2017.

According to the president and the CEO of Novadaq Rick Mangat, the transaction with Stryker confirms "the exclusive value" of the products Novadaq.^[1]

Notes